Dissemination of multidrug-resistant blaCTX-M-15/IncFIIk plasmids in Klebsiella pneumoniae isolates from hospital- and community-acquired human infections in Tunisia

Diagnostic Microbiology and Infectious Disease

Volumn 83, Issue 3, 2015, Pages 298-304

  Mansour, Wejdene ^b,c   Grami, Raoudha ^a,b   Ben Haj Khalifa, Anis ^d   Dahmen, Safia ^b,c   Châtre, Pierre ^a   Haenni, Marisa ^a   Aouni, Mahjoub ^b   Madec, Jean Yves ^a  

^a ANSES Site de Lyon   (France)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

^d Tahar Sfar University Hospital   (Tunisia)

Author keywords

Community; ESBL; IncFII; Klebsiella pneumoniae; Nosocomial; Tunisia

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; ENROFLOXACIN; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; NETILMICIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; TRIMETHOPRIM; BETA LACTAMASE; BETA-LACTAMASE CTX-M-15;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BLACTX M 15 GENE; CLONAL VARIATION; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; DNA SEQUENCE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; GENE IDENTIFICATION; GENE SEQUENCE; GENE TRANSFER; HOSPITAL INFECTION; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUNISIA; ANALYSIS; CLASSIFICATION; CROSS INFECTION; DRUG EFFECTS; GENETIC VARIATION; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; MOLECULAR TYPING; PULSED FIELD GEL ELECTROPHORESIS; SOUTHERN BLOTTING;

BETA-LACTAMASES; BLOTTING, SOUTHERN; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENETIC VARIATION; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MOLECULAR TYPING; PLASMIDS; RETROSPECTIVE STUDIES; TUNISIA;

EID: 84943587976     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.07.023     Document Type: Article

References (47)

1. Abbassi M.S., Ruiz E., Sáenz Y., Mechergui A., Ben Hassen A., Torres C. Genetic background of quinolone resistance in CTX-M-15-producing Klebsiella pneumonia and Escherichia coli strains in Tunisia. J Chemother 2010, 22:66-67.
2. Abbassi M.S., Ruiz E., Sáenz Y., Mechergui A., Ben Hassen A., Torres C. Genetic background of quinolone resistance in CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains in Tunisia. J Chemother 2010, 22:66-67.
3. Arlet G., Rouveau M., Philippon A. Substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum beta-lactamase. FEMS Microbiol Lett 1997, 152:163-167.
4. Barton B.M., Harding G.P., Zuccarelli A.J. A general method for detecting and sizing large plasmids. Anal Biochem 1995, 226:235-240.
5. Ben Achour N., Mercuri P.S., Ben Moussa M., Galleni M., Belhadj O. Characterization of a novel extended-spectrum TEM-type beta-lactamase, TEM-164, in a clinical strain of Klebsiella pneumoniae in Tunisia. Microb Drug Resist 2009, 15:195-199.
6. Ben Achour N., Mercuri P.S., Power P., Belhadj C., Ben Moussa M., Galleni M., et al. First detection of CTX-M-28 in a Tunisian hospital from a cefotaxime-resistant Klebsiella pneumoniae strain. Pathol Biol (Paris) 2009, 57:343-348.
7. Ben Haj Khalifa A., Khedher M. Epidemiological study of Klebsiella spp. uropathogenic strains producing extended-spectrum β-lactamase in a Tunisian university hospital, 2009. Pathol Biol 2012, 60:e1-e5.
8. Ben Sallem R., Ben Slama K., Estepa V., Jouini A., Gharsa H., Klibi N., et al. Prevalence and characterization of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia. Eur J Clin Microbiol Infect Dis 2012, 31:1511-1516.
9. Ben Slama K., Ben Sallem R., Jouini A., Rachid S., Moussa L., Saenz Y., et al. Diversity of genetic lineages among CTX-M-15 and CTX-M-14 producing Escherichia coli strains in a Tunisian hospital. Curr Microbiol 2011, 62:1794-1801.
10. Calhau V., Boaventura L., Ribeiro G., Mendonça N., da Silva G.J. Molecular characterization of Klebsiella pneumoniae isolated from renal transplanted patients: virulence markers, extended-spectrum β-lactamases, and genetic relatedness. Diagn Microbiol Infect Dis 2014, 10.1016/j.
11. Cantón R., Novais A., Valverde A., Machado E., Peixe L., Baquero F., et al. Prevalence and spread of extended-spectrum-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008, 14:144-153.
12. Caratolli A., Bertini A., Villa L., Falbo V, Hopkins KL, Threlfall EJ Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005, 63:219-228.
13. Carattoli A. Plasmids and the spread of resistance. Int J Med Microbiol 2013, 303:298-304.
14. Cavaco L.M., Hasman H., Xia S., Aarestrup F.M. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother 2009, 53(2):603-608.
15. Chouchani C., El Salabi A., Marrakchi R., Abouelkacem N., Walsh T.R. Occurrence of clinical isolates of Klebsiella pneumoniae harboring chromosomally mediated and plasmid-mediated CTX-M-15 β-lactamase in a Tunisian hospital. Can J Microbiol 2012, 58:1099-1103.
16. Dahmen S., Bettaieb D., Mansour W., Boujaafar N., Bouallègue O., Arlet G. Characterization and molecular epidemiology of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in a Tunisian University Hospital. Microb Drug Resist 2010, 16:163-170.
17. D'Andrea M.M., Arena F., Pallecchi L., Rossolini G.M. CTX-M-type beta-lactamases: a successful story of antibiotic resistance. Int J Med Microbiol 2013, 303:305-317.
18. Denton M. Enterobacteriaceae. Int J Antimicrob Agents 2007, 3:S9-S22.
19. Diancourt L., Passet V., Verhoef J., Grimont P.A., Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005, 43:4178-4182.
20. Eckert C., Gautier V., Saladin-Allard M., Hidri N., Verdet C., Ould-Hocine Z., et al. Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 2004, 48:1249-1255.
21. Elhani D., Bakir L., Aouni M., Passet V., Arlet G., Brisse S., et al. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005. Clin Microbiol Infect 2010, 16(2):157-164.
22. Ferjani S., Saidani M., Ennigrou S., Hsairi M., Slim A.F., Boutiba Ben Boubaker I. Multidrug resistance and high virulence genotype in uropathogenic Escherichia coli due to diffusion of ST131 clonal group producing CTX-M-15: an emerging problem in a Tunisian hospital. Folia Microbiol (Praha) 2014, 59:257-262.
23. Hammami S., Boutiba-Ben Boubaker I., Saidani M., Lakhal E., Ben Hassen A., Kamoun A., et al. Characterization and molecular epidemiology of extended spectrum beta-lactamase producing Enterobacter cloacae isolated from a Tunisian hospital. Microb Drug Resist 2012, 18:59-65.
24. Hammami S., Saidani M., Ferjeni S., Aissa I., Slim A., Boutiba-Ben Boubaker I. Characterization of extended spectrum β-lactamase-producing Escherichia coli in community-acquired urinary tract infections in Tunisia. Microb Drug Resist 2013, 19:231-236.
25. Kieser T. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 1984, 12:19-36.
26. Kim H.B., Wang M., Park C.H., Kim E.C., Jacoby G.A., Hooper D.C. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother 2009, 53(8):3582-3584.
27. Lahlaoui H., Anis B.H., Mohamed K., Mohamed B.M. Emergence of SHV-12 extended spectrum beta-lactamase among clinical isolates of Enterobacter cloacae in Tunisia. Microb Pathog 2012, 53:64-65.
28. Lavollay M., Mamlouk K., Frank T., Akpabie A., Burghoffer B., Ben Redjeb S., et al. Clonal dissemination of a CTX-M-15 beta-lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui. Antimicrob Agents Chemother 2006, 50:2433-2438.
29. Lin W.H., Kao C.Y., Yang D.C., Tseng C.C., Wu A.B., Teng C.H., et al. Clinical and microbiological characteristics of Klebsiella pneumoniae from community-acquired recurrent urinary tract infections. Eur J Clin Microbiol Infect Dis 2014, 33(9):1533-1539.
30. CTX-M-15) genetic structures. Antimicrob Agents Chemother 2009, 53:1630-1635.
31. Ma J., Zeng Z., Chen Z., Xu X., Wang X., Deng Y., et al. High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals. Antimicrob Agents Chemother 2009, 53(2):519-524.
32. Mammina C., Bonura C., Aleo A., Fasciana T., Brunelli T., Pesavento G., et al. Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy. Int J Antimicrob Agents 2012, 39:543-545.
33. Mezzatesta M.L., Gona F., Caio C., Adembri C., Dell'utri P., Santagati M., et al. Emergence of an extensively drug-resistant ArmA- and KPC-2-producing ST101 Klebsiella pneumoniae clone in Italy. J Antimicrob Chemother 2013, 68:1932-1934.
34. Mnif B., Harhour H., Jdidi J., Mahjoubi F., Genel N., Arlet G., et al. Molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in Tunisia and characterization of their virulence factors and plasmid addiction systems. BMC Microbiol 2013, 13:147.
35. Nicolas-Chanoine M.-H., Bertrand X., Madec J.-Y. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 2014, 27:543-574.
36. Park C.H., Robicesk A., Jacoby G.A., Sahm D., Hooper D.C. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006, 50(11):3953-3955.
37. Paterson D.L., Bonomo R.A. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005, 18:657-686.
38. Peirano G., Costello M., Pitout J.D. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Int J Antimicrob Agents 2010, 36:19-23.
39. Potron A, Poirel L, Rondinaud E, Nordman P Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill 2013, 18(13):657-686. [pii:20549].
40. Robicsek A., Strahilevitz J., Sahm D.F., Jacoby G.A., Hooper D.C. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from United States. Antimicrob Agents Chemother 2006, 50(8):2872-2874.
41. Rossolini G.M., D'Andrea M.M., Mugnaioli C. The spread of CTX-M-type extended-spectrum beta-lactamases. Clin Microbiol Infect 2008, 14:33-41.
42. Sana F., Mabrouka S., Claudine Q., Faouzi S.A., Ilhem B.B., Véronique D. Prevalence and characterization of uropathogenic Escherichia coli harboring plasmid-mediated quinolone resistance in a Tunisian university hospital. Diagn Microbiol Infect Dis 2014, 10.1016/j.
43. Shibata N., Kurokawa H., Doi Y., Yagi T., Yamane K., Wachino J., et al. PCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated gram-negative bacilli in Japan. Antimicrob Agents Chemother 2006, 50:791-795.
44. Tarchouna M., Ferjani A., Tilouche S., Marzouk M., Bouguila J., Boughamoura L., et al. Screening at admission for carrier prevalence of multidrug-resistant organisms in a pediatric unit. Am J Infect Control 2014, 42:88-89.
45. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
46. Villa L., Garcia-Fernandez A., Fortini D., Carattoli A. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother 2010, 65(12):2518-2529.
47. Wolfe C.M., Cohen B., Larson E. Prevalence and risk factors for antibiotic-resistant community-associated bloodstream infections. J Infect Public Health 2014, [Epub ahead of print]. 10.1016/j.jiph.2014.01.001.